Skip to content
10-K

Annual Report

NUTRALIFE BIOSCIENCES, INC.

0001493152-22-009623

← back to feed
Filed
Apr 11, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Mar 23, 2022 174.97M sh
Operating Cash Flow FY 2021 · Dec 31, 2021 −$487.39K
Operating Cash Flow FY 2021 · Dec 31, 2020 −$1.28M
Long Term Debt FY 2021 · Dec 31, 2021 $10K
Long Term Debt FY 2021 · Dec 31, 2020 $106.7K
Cash And Equivalents FY 2021 · Dec 31, 2021 $135.77K
Cash And Equivalents FY 2021 · Dec 31, 2020 $742
Stockholders Equity FY 2021 · Dec 31, 2021 −$712.53K
Stockholders Equity FY 2021 · Dec 31, 2020 $301.11K
Stockholders Equity FY 2021 · Dec 31, 2019 $1.59M
Current Liabilities FY 2021 · Dec 31, 2021 $5.2M
Current Liabilities FY 2021 · Dec 31, 2020 $3.78M
Total Liabilities FY 2021 · Dec 31, 2021 $5.56M
Total Liabilities FY 2021 · Dec 31, 2020 $4.41M
Current Assets FY 2021 · Dec 31, 2021 $518.3K
Current Assets FY 2021 · Dec 31, 2020 $722.46K
Total Assets FY 2021 · Dec 31, 2021 $4.85M
Total Assets FY 2021 · Dec 31, 2020 $4.71M
Net Income FY 2021 · Dec 31, 2021 −$5.83M
Net Income FY 2021 · Dec 31, 2020 −$2.89M
Operating Income FY 2021 · Dec 31, 2021 −$4.47M
Operating Income FY 2021 · Dec 31, 2020 −$1.97M
Gross Profit FY 2021 · Dec 31, 2021 $83.59K
Gross Profit FY 2021 · Dec 31, 2020 $509.85K
Revenue FY 2021 · Dec 31, 2021 $626.62K
Revenue FY 2021 · Dec 31, 2020 $1.26M